CEMEDIC
Buenos Aires, Argentina
General hospital in Buenos Aires
CFD, Cnel. Ramón L. Falcón 5206, C1440 CABA
About CEMEDIC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CEMEDIC
During the past decade, CEMEDIC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 7 clinical trials were completed, i.e. on
average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
2019-09-16
2023-03-23
Withdrawn
0
Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease
2018-02-28
2022-01-30
Unknown status
120
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CEMEDIC" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Boehringer Ingelheim" with 4 trials
sponsored, "Bayer" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bio Sidus SA"
with 2 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CEMEDIC"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at CEMEDIC
According to Clinical.Site data, the most researched conditions in "CEMEDIC" are
"Heart Failure" (4 trials), "Type 2 Diabetes Mellitus" (3 trials), "Atrial Fibrillation" (2 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "CEMEDIC" in a lesser frequency.
Clinical Trials Intervention Types at CEMEDIC
Most popular intervention types in "CEMEDIC" are "Drug" (16 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Tirzepatide" (4 trials), "Empagliflozin" (3 trials), "Insulin Degludec" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CEMEDIC
The vast majority of trials in "CEMEDIC" are
20 trials for "All" genders.
Clinical Trials Status at CEMEDIC
Currently, there are NaN active trials in "CEMEDIC".
undefined are not yet recruiting,
5 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in CEMEDIC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CEMEDIC, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".